Adalimumab Market Growth Fueled by Rising Prevalence of Chronic...

blog ekledi Oyun

2026-06-05 13:22:07

Adalimumab Market Growth Fueled by Rising Prevalence of Chronic Inflammatory Diseases

The global Adalimumab Market is witnessing significant growth, driven by the increasing burden of chronic inflammatory and autoimmune diseases worldwide. Adalimumab, a monoclonal antibody that targets tumor necrosis factor-alpha (TNF-α), has become one of the most widely prescribed biologic therapies due to its proven efficacy across multiple indications. According to The...

0 Yorumlar 0 Paylaşımlar 54 Görüntülenme 0 İncelemeler